NRx Pharmaceuticals Stock Rises 33% on Psychiatry Clinic Acquisition

Dow Jones

01-03

By Katherine Hamilton

NRx Pharmaceuticals shares gained after the company said it would buy California psychiatry clinic Kadima Neuropsychiatry Institute.

The stock rose Thursday to $2.92, reaching a six-month high. Shares are down 36% over the past 12 months.

Kadima, based in La Jolla, Calif., is expected to become the flagship clinic for Hope Therapeutics, a mental-health-services subsidiary of NRx. Hope is planning to develop an international network of psychiatry clinics designed to treat depression, anxiety and post-traumatic stress disorder.

Once the acquisition is complete, David Feifel, Kadima's founder and chief executive, will serve as chief medical innovation officer of Hope.

Kadima was among the first psychiatry clinics to use ketamine therapy to treat central-nervous-system disorders. It also has a research division and contracts with the Department of Veterans Affairs.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

January 02, 2025 12:22 ET (17:22 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2500497283"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2500497283\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2500497283?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-03 01:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2500497283","market":"nz","top_or_hot":-1,"title":"NRx Pharmaceuticals Stock Rises 33% on Psychiatry Clinic Acquisition","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Katherine Hamilton \n</p>\n<pre>\n \n</pre>\n<p>\n  NRx Pharmaceuticals shares gained after the company said it would buy California psychiatry clinic Kadima Neuropsychiatry Institute. \n</p>\n<p>\n  The stock rose Thursday to $2.92, reaching a six-month high. Shares are down 36% over the past 12 months. \n</p>\n<p>\n  Kadima, based in La Jolla, Calif., is expected to become the flagship clinic for Hope <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>, a mental-health-services subsidiary of NRx. Hope is planning to develop an international network of psychiatry clinics designed to treat depression, anxiety and post-traumatic stress disorder. \n</p>\n<p>\n  Once the acquisition is complete, David Feifel, Kadima's founder and chief executive, will serve as chief medical innovation officer of Hope. \n</p>\n<p>\n  Kadima was among the first psychiatry clinics to use ketamine therapy to treat central-nervous-system disorders. It also has a research division and contracts with the Department of Veterans Affairs. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 02, 2025 12:22 ET (17:22 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NRx Pharmaceuticals Stock Rises 33% on Psychiatry Clinic Acquisition</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNRx Pharmaceuticals Stock Rises 33% on Psychiatry Clinic Acquisition\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-01-03 01:22</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Katherine Hamilton \n</p>\n<pre>\n \n</pre>\n<p>\n  NRx Pharmaceuticals shares gained after the company said it would buy California psychiatry clinic Kadima Neuropsychiatry Institute. \n</p>\n<p>\n  The stock rose Thursday to $2.92, reaching a six-month high. Shares are down 36% over the past 12 months. \n</p>\n<p>\n  Kadima, based in La Jolla, Calif., is expected to become the flagship clinic for Hope <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>, a mental-health-services subsidiary of NRx. Hope is planning to develop an international network of psychiatry clinics designed to treat depression, anxiety and post-traumatic stress disorder. \n</p>\n<p>\n  Once the acquisition is complete, David Feifel, Kadima's founder and chief executive, will serve as chief medical innovation officer of Hope. \n</p>\n<p>\n  Kadima was among the first psychiatry clinics to use ketamine therapy to treat central-nervous-system disorders. It also has a research division and contracts with the Department of Veterans Affairs. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 02, 2025 12:22 ET (17:22 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"製藥","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2500497283","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2500497283","pubTimestamp":1735838520,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"NRx Pharmaceuticals shares gained after the company said it would buy California psychiatry clinic Kadima Neuropsychiatry Institute.The stock rose Thursday to $2.92, reaching a six-month high. Shares are down 36% over the past 12 months.Kadima, based in La Jolla, Calif., is expected to become the flagship clinic for Hope Therapeutics, a mental-health-services subsidiary of NRx. Hope is planning to develop an international network of psychiatry clinics designed to treat depression, anxiety and post-traumatic stress disorder.Once the acquisition is complete, David Feifel, Kadima's founder and chief executive, will serve as chief medical innovation officer of Hope.Kadima was among the first psychiatry clinics to use ketamine therapy to treat central-nervous-system disorders. It also has a research division and contracts with the Department of Veterans Affairs.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","NRXP":"NRX Pharmaceuticals Inc."},"translate_title":"NRx Pharmaceuticals股价因收购精神病诊所而上涨33%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NRXP":0.9},"content_text":"By Katherine Hamilton \n\n\n \n\n\n  NRx Pharmaceuticals shares gained after the company said it would buy California psychiatry clinic Kadima Neuropsychiatry Institute. \n\n\n  The stock rose Thursday to $2.92, reaching a six-month high. Shares are down 36% over the past 12 months. \n\n\n  Kadima, based in La Jolla, Calif., is expected to become the flagship clinic for Hope Therapeutics, a mental-health-services subsidiary of NRx. Hope is planning to develop an international network of psychiatry clinics designed to treat depression, anxiety and post-traumatic stress disorder. \n\n\n  Once the acquisition is complete, David Feifel, Kadima's founder and chief executive, will serve as chief medical innovation officer of Hope. \n\n\n  Kadima was among the first psychiatry clinics to use ketamine therapy to treat central-nervous-system disorders. It also has a research division and contracts with the Department of Veterans Affairs. \n\n\n \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 02, 2025 12:22 ET (17:22 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,merge","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}